{
    "clinical_study": {
        "@rank": "134475", 
        "acronym": "EDIRAPHIS", 
        "biospec_descr": {
            "textblock": "Urine, serum and Histoplasma capsulatum var. capsulatum strains"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Histoplasma capsulatum var. capsulatum histoplasmosis is the leading cause of acquired\n      immunodeficiency syndrome (AIDS) and death in French Guiana and probably in the Amazon. The\n      diagnosis of this disease requires invasives procedures, laboratory performance, and delays\n      up to several weeks. The Mycotic Diseases Branch of the Centers for Disease Control and\n      Prevention (CDC) has established a rapid, sensitive and specific ELISA test for blood and\n      urine samples that looks interesting in endemic areas, particularly in developing countries.\n      The study aims to measure the proportion of HIV-infected patients hospitalized or in\n      outpatient awaiting hospitalization for a suspicion of infectious syndrome whose serum\n      and/or urinary antigen detection tests are positive for Histoplasma capsulatum var.\n      capsulatum."
        }, 
        "brief_title": "Prevalence of Histoplasmosis in HIV + Patients With a Rapid Diagnostic Test in West Indies", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "HIV", 
        "condition_browse": {
            "mesh_term": "Histoplasmosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult (aged 18 or over).\n\n          -  Patient seen while hospitalized or in outpatient awaiting hospitalization.\n\n          -  HIV1 or HIV2 infection confirmed by techniques validated in France and in Suriname,\n             either before the episode considered, or discovered concomitantly.\n\n          -  Patient presenting at least one of the three followings items: an alteration of their\n             general condition (with a grade 1 according to the WHO Performance Status scale)\n             and/or a fever and/or symptoms suggestive of an infectious syndrome.\n\n          -  Medical prescription for the collection of blood and urine specimens to test for an\n             infectious agent within 7 days following admission to the hospital.\n\n          -  Written consent to participate in the study obtained.\n\n        Exclusion Criteria:\n\n          -  Refusal to participate in the study.\n\n          -  Patient in a critical condition that doesn't allow physicians to get an informed\n             consent without a legal representative to represent him and sign a consent form for\n             the patient participation in the study.\n\n          -  Ongoing antifungal treatment or antifungal treatment stopped during the month\n             preceding the inclusion date (topic antifungal therapy not considered at this point).\n\n          -  Patient in detention at the time of admission to the hospital."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult (aged 18 or over), seen while hospitalized or in outpatient awaiting\n        hospitalization, HIV1 or HIV2 infection confirmed by techniques validated in France and in\n        Suriname, either before the episode considered, or discovered concomitantly, and\n        presenting at least one of the three followings items: an alteration of their general\n        condition (with a grade 1 according to the WHO Performance Status scale) and/or a fever\n        and/or symptoms suggestive of an infectious syndrome."
            }
        }, 
        "enrollment": {
            "#text": "727", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884779", 
            "org_study_id": "ANRS 12260 EDIRAPHIS"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HIV", 
            "Histoplasmosis", 
            "Histoplasma capsulatum var.capsulatum", 
            "ELISA test"
        ], 
        "lastchanged_date": "October 29, 2013", 
        "location": [
            {
                "contact": {
                    "email": "antoine.adenis@gmail.com", 
                    "last_name": "Antoine ADENIS, MD, MPH", 
                    "phone": "+594 594 39 50 08"
                }, 
                "facility": {
                    "address": {
                        "city": "Pointe-\u00e0-Pitre", 
                        "country": "France", 
                        "state": "Guadeloupe", 
                        "zip": "97159"
                    }, 
                    "name": "Pointe-\u00e0-Pitre University Hospital"
                }, 
                "investigator": {
                    "last_name": "Gilles BEAUCAIRE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "antoine.adenis@gmail.com", 
                    "last_name": "Antoine ADENIS, MD, MPH", 
                    "phone": "+594 594 39 50 08"
                }, 
                "facility": {
                    "address": {
                        "city": "Cayenne", 
                        "country": "France", 
                        "state": "Guyane", 
                        "zip": "97306"
                    }, 
                    "name": "Cayenne General Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Pierre COUPPIE, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "F\u00e9lix DJOSSOU, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "antoine.adenis@gmail.com", 
                    "last_name": "Antoine ADENIS, MD, MPH", 
                    "phone": "+594 594 39 50 08"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint-Laurent-du-Maroni", 
                        "country": "France", 
                        "state": "Guyane", 
                        "zip": "97320"
                    }, 
                    "name": "Western French Guiana Hospital"
                }, 
                "investigator": {
                    "last_name": "Vincent VANTILCKE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "antoine.adenis@gmail.com", 
                    "last_name": "Antoine ADENIS, MD, MPH", 
                    "phone": "+594 594 39 50 08"
                }, 
                "facility": {
                    "address": {
                        "city": "Fort-de-France", 
                        "country": "France", 
                        "state": "Martinique", 
                        "zip": "97261"
                    }, 
                    "name": "Fort-de-France University Hospital"
                }, 
                "investigator": {
                    "last_name": "Andr\u00e9 CABIE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sigi_macdonald@live.com", 
                    "last_name": "Sigrid MAC DONALD, MD", 
                    "phone": "+597 7190800"
                }, 
                "facility": {
                    "address": {
                        "city": "Paramaribo", 
                        "country": "Suriname"
                    }, 
                    "name": "Diakonessenhuis hospital"
                }, 
                "investigator": {
                    "last_name": "Marja VAN EER, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sigi_macdonald@live.com", 
                    "last_name": "Sigrid MAC DONALD, MD", 
                    "phone": "+597 7190800"
                }, 
                "facility": {
                    "address": {
                        "city": "Paramaribo", 
                        "country": "Suriname"
                    }, 
                    "name": "'s Lands Hospital"
                }, 
                "investigator": {
                    "last_name": "Aruna JARBANDHAN, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sigi_macdonald@live.com", 
                    "last_name": "Sigrid MAC DONALD, MD", 
                    "phone": "+597 7190800"
                }, 
                "facility": {
                    "address": {
                        "city": "Paramaribo", 
                        "country": "Suriname"
                    }, 
                    "name": "Academisch Ziekenhuis Paramaribo Hospital"
                }, 
                "investigator": {
                    "last_name": "Stephen G VREDEN, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Suriname"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Histoplasmosis in the Guiana Shield and the French West Indies: Evaluating Prevalence in HIV + Patients With a Rapid Diagnostic Test Using an ELISA Capture Method for the Detection of Histoplasma Antigens in Blood and Urine.", 
        "overall_contact": {
            "email": "mathieu.nacher@ch.cayenne.fr", 
            "last_name": "Mathieu NACHER, MD, PhD", 
            "phone": "+594 594 39 50 24"
        }, 
        "overall_contact_backup": {
            "email": "antoine.adenis@gmail.com", 
            "last_name": "Antoine ADENIS, MD, MPH", 
            "phone": "+594 594 39 50 08"
        }, 
        "overall_official": [
            {
                "affiliation": "CIE 802 Inserm / DGOS", 
                "last_name": "Mathieu NACHER, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Foundation for Scientific Research Suriname (SWOS)", 
                "last_name": "Stephen G VREDEN, MD, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Suriname:Ministerie van Volksgezondheid", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of HIV-infected patients hospitalized or in outpatient awaiting hospitalization for a suspicion of infectious syndrome whose serum and/or urinary antigen detection tests are positive for Histoplasma capsulatum var. capsulatum.", 
            "safety_issue": "No", 
            "time_frame": "At the time of inclusion (baseline)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884779"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Sensitivity of the ELISA test on urine and blood specimens", 
                "safety_issue": "No", 
                "time_frame": "At the time of inclusion (baseline)"
            }, 
            {
                "measure": "Sensibility of the ELISA test on urine and blood specimens", 
                "safety_issue": "No", 
                "time_frame": "At the time of inclusion (baseline)"
            }, 
            {
                "measure": "Negative predictive value of the ELISA test on urine and blood specimens", 
                "safety_issue": "No", 
                "time_frame": "At the time of inclusion (baseline)"
            }, 
            {
                "measure": "Comparison of the distribution of Histoplasma antigen concentrations in urine and serum specimens according to severity of cases of histoplasmosis due to Histoplasma capsulatum var. capsulatum", 
                "safety_issue": "No", 
                "time_frame": "At the time of inclusion (baseline)"
            }, 
            {
                "measure": "Comparison of the socio-demographic, clinical, paraclinical and therapeutic characteristics according to severity of cases of histoplasmosis due to Histoplasma capsulatum var. capsulatum", 
                "safety_issue": "No", 
                "time_frame": "30 days or 90 days after inclusion"
            }, 
            {
                "measure": "Comparison of the factors for environmental exposure to Histoplasma capsulatum var capsulatum between patients with a positive ELISA test and/or fungal culture for histoplasmosis and those who tested negative for histoplasmosis", 
                "safety_issue": "No", 
                "time_frame": "At the time of inclusion"
            }, 
            {
                "measure": "Frequency of histoplasmosis compared to the other main diagnoses according to three sets of comparisons: positive ELISA test and positive fungal culture; positive ELISA test and negative fungal culture; negative ELISA test and positive fungal culture", 
                "safety_issue": "No", 
                "time_frame": "90 days after inclusion"
            }, 
            {
                "measure": "Comparison of the socio-demographic, clinical, paraclinical, therapeutic and survival outcome characteristics of cases of histoplasmosis compared to those who tested negative for histoplasmosis", 
                "safety_issue": "No", 
                "time_frame": "90 days after inclusion"
            }, 
            {
                "measure": "Identify the prognostic factors for short-term unfavourable progression of cases of histoplasmosis due to Histoplasma capsulatum  var. capsulatum confirmed by ELISA test and/or by fungal culture", 
                "safety_issue": "No", 
                "time_frame": "30 days and 90 days after inclusion"
            }
        ], 
        "source": "French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "90 Days", 
        "verification_date": "October 2013"
    }
}